Yan X - Search Results

1

Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices.

Du J, Yan X, Mi S, Li Y, Ji H, Hou K, Ma S, Ba Y, Zhou P, Chen L, Xie R, Hu S. Du J, et al. Among authors: yan x. Front Cell Dev Biol. 2020 Oct 19;8:558961. doi: 10.3389/fcell.2020.558961. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33195193 Free PMC article.

2

Pituitary adenoma secondary to primary hypothyroidism: Two case reports.

Du J, Ji H, Jin J, Gao S, Yan X, Hu S. Du J, et al. Among authors: yan x. Medicine (Baltimore). 2020 Feb;99(8):e19222. doi: 10.1097/MD.0000000000019222. Medicine (Baltimore). 2020. PMID: 32080117 Free PMC article.

3

Ji H, Zhao H, Jin J, Liu Z, Gao X, Wang F, Dong J, Yan X, Zhang J, Wang N, Du J, Hu S. Ji H, et al. Among authors: yan x. Front Genet. 2022 Jan 17;12:736187. doi: 10.3389/fgene.2021.736187. eCollection 2021. Front Genet. 2022. PMID: 35111196 Free PMC article.

4

5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas.

Zhang J, Wang N, Wu J, Gao X, Zhao H, Liu Z, Yan X, Dong J, Wang F, Ba Y, Ma S, Jin J, Du J, Ji H, Hu S. Zhang J, et al. Among authors: yan x. Front Immunol. 2022 Mar 3;13:844778. doi: 10.3389/fimmu.2022.844778. eCollection 2022. Front Immunol. 2022. PMID: 35309316 Free PMC article.

5

Dong J, Zhao H, Wang F, Jin J, Ji H, Yan X, Wang N, Zhang J, Hu S. Dong J, et al. Among authors: yan x. Front Neurol. 2022 Mar 10;13:829926. doi: 10.3389/fneur.2022.829926. eCollection 2022. Front Neurol. 2022. PMID: 35359663 Free PMC article.

6

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma.

Yan X, Ji H, Liu Z, Ma S, Dong J, Jiang X, Hu X, Wang F, Zhao H, Jin J, Zhang J, Wang N, Du J, Hu S. Yan X, et al. Front Genet. 2022 Apr 26;13:880864. doi: 10.3389/fgene.2022.880864. eCollection 2022. Front Genet. 2022. PMID: 35559020 Free PMC article.

7

Extended Application of Genomic Selection to Screen Multi-Omics Data for the Development of Novel Pyroptosis-Immune Signatures and Predicting Immunotherapy of Glioma.

Ma S, Wang F, Wang N, Jin J, Yan X, Wang L, Zheng X, Hu S, Du J. Ma S, et al. Among authors: yan x. Front Pharmacol. 2022 May 10;13:893160. doi: 10.3389/fphar.2022.893160. eCollection 2022. Front Pharmacol. 2022. PMID: 35620284 Free PMC article.

8

Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas.

Wu J, He J, Zhang J, Ji H, Wang N, Ma S, Yan X, Gao X, Du J, Liu Z, Hu S. Wu J, et al. Among authors: yan x. Front Cell Dev Biol. 2022 May 17;10:887693. doi: 10.3389/fcell.2022.887693. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35656554 Free PMC article.

9

IGFBPs were associated with stemness, inflammation, extracellular matrix remodeling and poor prognosis of low-grade glioma.

Liu Z, Ji H, Fu W, Ma S, Zhao H, Wang F, Dong J, Yan X, Zhang J, Wang N, Wu J, Hu S. Liu Z, et al. Among authors: yan x. Front Endocrinol (Lausanne). 2022 Aug 3;13:943300. doi: 10.3389/fendo.2022.943300. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35992105 Free PMC article.

10

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma.

Yan X, Wang N, Dong J, Wang F, Zhang J, Hu X, Zhao H, Gao X, Liu Z, Li Y, Hu S. Yan X, et al. Front Mol Biosci. 2022 Aug 17;9:966843. doi: 10.3389/fmolb.2022.966843. eCollection 2022. Front Mol Biosci. 2022. PMID: 36060266 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,560 results

Search Page

Filters